Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novavax and PCV20 Co-administration in Adults Aged 60 and Older
NCT05767606Phase 4Unknown
- Sponsor
- Medical University of Vienna
- Start
- Mar 2023
- Primary completion
- Jul 2023
- Modality
- Nanoparticles, Small Molecules, Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of perflenapent, Prevnar 20 in coronavirus disease 2019 (COVID-19), pneumococcal infection, sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
perflenapentPrevnar 20
03
Conditions
coronavirus disease 2019 (COVID-19)pneumococcal infection
Beyond the preview
Go deeper on NCT05767606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05767606.